Skip to main content

Table 1 Baseline characteristics of the study cohort

From: Association of diabetes mellitus and glycemic control with left ventricular function and deformation in patients after acute myocardial infarction: a 3 T cardiac magnetic resonance study

 

Control (n = 71)

MI (DM−) (n = 113)

MI (DM+) (n = 95)

Baseline characteristics

 Age, years

58 ± 258.95

58.08 ± 1.88

60.76 ± 77

 Male, n (%)

55 (77.46%)

97 (85.84%)

85 (89.47%)

 BMI, kg/m2

23.31 (21.78, 25.27)

24.37 (22.31, 26.51)

25.16 (22.60, 27.22)

 Systolic blood pressure, mmHg

127.83 ± 16.19

122.99 ± 19.31

126.90 ± 22.44

 Diastolic blood pressure, mmHg

76.58 ± 10.16

75.17 ± 13.18

77.45 ± 11.83

 Heart rate, bpm

70.69 (63.59, 78.97)

70.44 (61.79, 80.22)

73.19 (65.81, 80.97)

Cardiovascular risk factors

 Previous/current smoker, n (%)

77 (68.14%)

60 (63.16%)

 Hyperlipidemia

65 (57.52%)

55 (57.89%)

 Hypertension

50 (44.25%)

57 (60.00%)

 Pervious PCI, n (%)

47 (41.59%)

43 (45.26%)

 Pervious GABG n (%)

 

0

2 (2.11%)

NYHA functional class, n

 I

33 (29.20%)

12 (12.63%)b

 II

41 (36.28%)

45 (47.37%)

 III

33 (29.20%)

31 (32.63%)

 IV

6 (5.31%)

7 (7.37%)

Culprit vessel n (%)

 Left main

3 (2.65%)

2 (2.11%)

 Left anterior descending

46 (40.71%)

41 (43.16%)

 Left circumflex

23 (20.35%)

18 (18.95%)

 Right coronary artery

41 (36.28%)

34 (35.79%)

Number of diseased vessels n (%)

 1

 

58 (51.33%)

36 (37.89%)

 2

 

34 (30.09%)

34 (35.79%)

 3

 

17 (15.04%)

23 (24.21%)

HbA1c, %

 

5.75 ± 0.46

7.90 (7.00, 8.90)b

Triglycerides, mmol/L

1.43 (0.95, 1.83)

1.44 (1.04, 2.27)

1.43 (0.93, 2.01)

Total cholesterol, mmol/L

4.33 ± 0.54

3.55 (3.19, 3.91)

3.24 (2.89, 3.98)

HDL, mmol/L

1.32 ± 0.34

1.04 (0.84, 1.24)

1.00 (0.82, 1.16)

LDL, mmol/L

2.56 ± 0.58

1.26 (1.16, 1.96)

1.86 (1.51, 2.39)

eGFR, mL/min/1.73m2

100.32 (87.00, 110.85)

84.97 (72.37, 96.21)

80.31 (65.69, 94.55)

Troponin, ng/L

 

14.20 (9.40, 28.60)

20.90 (11.20, 39.10)

NT-proBNP

311.00 (167.50, 766.00)

687.00 (155.50, 1916.50)b

Concomitant medication, n (%)

 Aspirin, n (%)

106 (93.81%)

90 (94.74%)

 ß-blockers, n (%)

92 (81.42%)

78 (82.11%)

 ACEI/ARB, n (%)

68 (60.18%)

65 (68.42%)

 Diuretics

46 (40.71%)

36 (37.89%)

 Calcium-channel blocker

84 (74.34%)

74 (77.89%)

 Insulin

12 (10.62%)

56 (58.95%)

 Statin, n (%)

89 (78.76%)

89 (93.68%)

  1. DM: diabetes mellitus; MI: myocardial infarction; BMI: body mass index; PCI: percutaneous transluminal coronary intervention; CABG: coronary artery bypass grafting; NYHA: New York Heart Association; HbA1c: glycated hemoglobin; HDL: high density lipoprotein; LDL: low density lipoprotein; eGFR estimated glomerular filtration rate; ACEI: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blockers
  2. a: p < 0.05 versus control group (Bonferroni’s)
  3. b: p < 0.05 versus MI patients without DM (Bonferroni’s)